WuXi XDC licenses WuXiTecan-2 ADC payload to Ona Therapeutics
WuXi XDC granted Ona Therapeutics an exclusive global license to its WuXiTecan-2 payload, including an upfront, milestone payments, and tiered royalties, plus CMC development and manufacturing support.
WuXi XDC granted Ona Therapeutics an exclusive global license to its WuXiTecan-2 payload—linker for one ADC target, with upfront, milestone payments, and tiered royalties. Material DetailsContext by AI AnalystThis extends WuXi XDC…